Background illustration for clinical trials search

Paid Clinical Trials Seattle

Discover 1,443 paid clinical trials in Seattle, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

for
Chronic Myelogenous Leukemia,
Location: Seattle WA, Edmonton, Cincinnati OH, Montreal,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1 - 18

Code: NCT07354074

Phase2, Recruiting

Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials

for
Duchenne Muscular Dystrophy (DMD), Cardiomyopathy,
Location: Seattle WA, Sacramento CA, Chicago IL, Indianapolis IN,
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 0+

Code: NCT07674758

Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Seattle WA, Tacoma WA, Vancouver, Portland OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase3, Recruiting

Optimal Ventilation for Cardiac Arrest

for
Cardiac Arrest (CA)
Location: Seattle WA, Palo Alto CA, Orange CA, Denver CO,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT07114510

Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Seattle WA, Tacoma WA, Portland OR, Spokane WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

for
Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
Location: Seattle WA, Palo Alto CA, Los Angeles CA, Aurora CO,
Sponsor: University of Iowa

Sex: All

Age: 0+

Code: NCT01193088

Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Seattle WA, Tacoma WA, Portland OR, Reno NV, Oakland CA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase3, Recruiting

A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

for
Duchene Muscular Dystrophy
Location: Seattle WA, Portland OR, Chicago IL, Little Rock AR,
Sponsor: ITF Therapeutics LLC

Sex: All

Age: 6+

Code: NCT07127978

Recruiting

Non-invasive Prediction of EArly Cardiac rEjection

for
Heart Transplant, Pediatric Heart Transplant, Rejection,
Location: Seattle WA, Palo Alto CA, Los Angeles CA, Denver CO,
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 6 - 25

Code: NCT07770659

Recruiting

Minima Stent System Post- Approval Study (PAS)

for
Pulmonary Artery Stenosis, Aortic Coarctation
Location: Seattle WA, Los Angeles CA, Aurora CO, Dallas TX,
Sponsor: Renata Medical

Sex: All

Age: 0+

Code: NCT06828770

Recruiting

Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

for
GRIN-related Neurodevelopmental Disorder
Location: Seattle WA, Palo Alto CA, Los Angeles CA, Aurora CO,
Sponsor: GRIN Therapeutics, Inc.

Sex: All

Age: 0 - 18

Code: NCT07224581

Phase3, Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for
Bronchiolitis Acute
Location: Seattle WA, Vancouver, Calgary, Sacramento CA, Lodi CA,
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

for
Focal Seizures
Location: Seattle WA, Portland OR, Murray UT, La Jolla CA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT07233239

Phase1, Recruiting

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Seattle WA, Portland OR, Spokane WA, Calgary,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT01790152

Recruiting

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

for
Solid Tumor (Excluding CNS), Liver Cell Carcinoma,
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 1 - 26

Code: NCT07148050

Phase1, Recruiting

Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients

for
Duchenne Muscular Dystrophy, Duchenne, DMD,
Location: Seattle WA, Los Angeles CA, Aurora CO, St Louis MO,
Sponsor: Satellos Bioscience, Inc.

Sex: Male

Age: 7 - 9

Code: NCT07287189

Phase2, Recruiting

Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.

for
Diabetes Mellitus, Type 1 Diabetes
Location: Seattle WA
Sponsor: University of British Columbia

Sex: All

Age: 16 - 19

Code: NCT07292558

Recruiting

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

for
Head and Neck Squamous Cell Carcinoma,
Location: Bremerton WA, Weston WI
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT02734537

Phase2, Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Seattle WA, Tacoma WA, Vancouver, Portland OR,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase3, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Seattle WA, Tacoma WA, Vancouver, Portland OR,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase3, Recruiting

As one of the fastest growing cities in America, Seattle stands out as a pivotal location for clinical research. Home to an extensive healthcare network and prominent research institutions, Seattle offers innovative approaches to clinical research and a significant contribution to medical science.

Leading centers such as the Fred Hutchinson Cancer Research Center, the University of Washington Medical Center, and the Seattle Children's Research Institute are at the forefront of groundbreaking studies.

Why choose Seattle for clinical trials?

For those considering participating in a clinical trial, there are several reasons why Seattle is a prime choice. The city is home to a robust network of leading research institutions, which are known for their pioneering work and advanced medical research. Seattle’s collaborative environment and emphasis on innovation enhance the quality and impact of clinical studies.

By participating in a clinical trial in Seattle, you gain access to some of the most advanced research and treatments available, while also contributing to significant medical discoveries. The city's commitment to cutting-edge science and a supportive research infrastructure make it an ideal location for advancing medical knowledge and improving future healthcare outcomes.

Common conditions studied in Seattle

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Seattle